We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Firm Incentives Will Suffer Under WHO Plan, Expert Says
Drug Firm Incentives Will Suffer Under WHO Plan, Expert Says
June 9, 2006
A World Health Organization (WHO) initiative to loosen drug and diagnostic intellectual property laws for developing countries could encourage less-needy countries to invoke compulsory licensing and remove the financial incentive to develop new treatments, one industry expert told WDL.